Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Jakob Michael Riedl, Florian Posch, Florian Moik, Angelika Bezan, Joanna Szkandera, Maria Anna Smolle, Anne-Katrin Kasparek, Martin Pichler, Herbert Stöger, Michael Stotz, Armin Gerger
Published Oct 4, 2017 · Vol. 8, No. 56 · pp. 96048-96061
Ting Zhang, Jie Xiang, Bota Cui, Zhi He, Pan Li, Hai Chen, Lijuan Xu, Guozhong Ji, Yongzhan Nie, Kaichun Wu, Daiming Fan, Guangming Huang, Jianling Bai, Faming Zhang
Published Oct 4, 2017 · Vol. 8, No. 51 · pp. 88894-88903
Oscar M.J.A. Stassen, Emma J. van Bodegraven, Fabrizio Giuliani, Martina Moeton, Regina Kanski, Jacqueline A. Sluijs, Miriam E. van Strien, Willem Kamphuis, Pierre A.J. Robe, Elly M. Hol
Published Oct 4, 2017 · Vol. 8, No. 50 · pp. 88104-88121
